A 37-year-old woman with chronic hepatitis virus C (HCV) (genotype 2, 5.8 log IU/mL) was admitted with high fever and severe dyspnea without skin or ocular lesions. Laboratory data are shown in Table 1 . Three months earlier, she had been under therapy with pegylated interferon and ribavirin with normal chest radiograph. She had a remote history of intravenous drug abuse.
Plain computed tomography revealed small, diffuse, reticular small nodular lesions, ground glass appearance, mediastinal and bilateral hilar lymphadenopathy, and bilateral pleural effusion ( Figure 1a ).
All stains and cultures of bronchoalveolar lavage were negative for fungal, acid-fast bacilli, and other bacterial infections.
In this case, disseminated infection including miliary tuberculosis and fungal infection, drug-induced interstitial pneumonia, intravenous talc granulomatosis, extrinsic allergic alveolitis, and pneumoconiosis needed to be differentiated; however, a definite diagnosis was made by the histological finding of non-necrotizing epithelioid granuloma with multinucleated giant cells (Figure 1b ). Emergency oxygen (15 l/min) and intravenous steroid pulse therapy was continued for 7 days followed by oral steroid tapering therapy.
At the 4-week follow-up, she recovered completely with almost normal chest radiograph finding ( Figure 1c ). The diagnosis of sarcoidosis necessitates appropriate chest radiograph findings, clinical symptoms, and histologic findings, as well as exclusion of other infections and neoplastic causes (1) .
Not a few cases of sarcoidosis manifesting lung lesion due to IFN therapy have been reported since first recognized case in 1987 (2); however, most have shown gradual and chronic clinical courses (3) (4) (5) . In our case, emergency therapy including oxygenation and steroid pulse therapy was needed. Although the exact pathogenesis of sarcoidosis remains unclear, a number of immune modulators have been implicated, including IFNs and HCV (3, 4) . 2017; 28: 75-6 Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C 
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